M. Liu

Therapeutic strategies for targeting telomerase in cancer

Wenjian Tang, J. Shi, Xing Chen, 2020, Medicinal research reviews.

Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.

Rui Zhang, Qingshan Li, X. Liu, 2021, Journal of medicinal chemistry.

Discovery and Anti-Inflammatory Activity Evaluation of a Novel CDK8 Inhibitor through Upregulation of IL-10 for the Treatment of Inflammatory Bowel Disease In Vivo.

J. Shi, M. Liu, Z. Zhang, 2022, Journal of medicinal chemistry.

Design and synthesis of novel pyrazolo[4,3-d]pyrimidines as potential therapeutic agents for acute lung injury

Xin Huang, J. Shi, M. Liu, 2019, Journal of enzyme inhibition and medicinal chemistry.

Design and Synthesis of a 2-Amino-pyridine Derivative as a Potent CDK8 Inhibitor for Anti-colorectal Cancer Therapy.

X. Liu, M. Liu, Xing-Xing Zhang, 2022, Journal of medicinal chemistry.

Novel Pyrazolo[4,3- d]pyrimidine as Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model.

Wenjian Tang, Xin Huang, J. Shi, 2019, Journal of medicinal chemistry.

Synthesis and biological evaluation of novel hybrids of phenylsulfonyl furoxan and phenstatin derivatives as potent anti-tumor agents.

Bo Zhang, Xin Huang, J. Shi, 2022, European journal of medicinal chemistry.

Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis.

Xin Huang, J. Shi, X. Liu, 2021, European journal of medicinal chemistry.